Study objectives: A frequent complication of the widely used Dumon silicone stent is its tendency to migrate when used in tracheal stenosis. We compared the clinical efficacy and complications (including migration) of the Dumon stent with a screw-thread stent, a device with an increased stent-to-wall contact surface and, theoretically, less tendency to migrate. 
I
n patients for whom tracheal surgery is not feasible as a primary therapy for the management of benign or malignant tracheal lesions, the placement
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of tracheal endoprostheses (stents) is being performed more frequently, with excellent clinical results. 1 Probably the most popular stent used in the management of tracheal obstructive lesions is the Dumon stent (Novatech; Aubagne, France), 2 a straight stent of molded silicone featuring regularly placed pitted studs on its outer surface to ensure adherence to the airway wall. A disadvantage of the Dumon stent is its tendency to migrate, especially when used in a short benign tracheal stenosis, an isolated tracheomalacia, or a tracheoesophageal fistula; in these indications, migration occurs in 17% to 22% of all cases. [3] [4] [5] Although rarely life threatening, stent migration usually requires reintervention under general anesthesia. In some cases, however, urgent reintubation with stent removal and/or replacement is necessary because of major airway compromise. In order to, theoretically, decrease the risk of tracheal stent migration, we asked MTW (Essen, Germany) to modify their screw-thread esophageal stents for tracheal use. The screw-thread stent surface increases the stent-to-wall contact surface. Furthermore, the screw-thread "clicks" into the tracheal cartilage rings when the latter are still present, thus increasing airway-wall adherence in benign or purely extrinsic compression. Preliminary results showed that stent placement and removal was accomplished easily and efficiently. 6 In that series, no stent migration had occurred. The aim of the present study is to compare the clinical efficacy and the occurrence of complications such as migration between the Dumon stent and the screw-thread stent in the management of benign and malignant tracheal stenosis.
Materials and Methods

Patients
Forty-six consecutive patients referred for the treatment of tracheal stenosis or obstruction were included in the study, and a total of 50 tracheal stents have been inserted. All relevant data concerning these patients were recorded in separate patient files and analyzed retrospectively. The patients were followed until death (those with malignant lesions) or are still in follow-up (those with malignant or benign lesions). The longest follow-up period has lasted approximately 6 years. The patient characteristics of the two study groups are shown in Table 1 . There were no significant differences in gender ratio, mean age, and nature (benign or malignant) of the tracheal obstruction between the patients receiving Dumon stents and the patients receiving screw-thread stents (Table 1) . Moreover, there were no differences in benign stenosis characteristics between the two patient groups (Table 1 ). An equal proportion of patients in both groups had prior treatment with Nd-YAG laser therapy (34% in the Dumon group vs 24% in the screw-thread group, p ϭ 0.6), be it for benign or malignant lesions. The type of stent used was determined by patient consent, tracheal diameter and, initially, by the size of the patient and the glottic aperture. The possibility of injuring the glottis was considered because the screw-thread stent is mounted on top of the bronchoscope during insertion, whereas the Dumon stent is inserted through the bronchoscope.
When it became clear through experience that no glottic damage occurred with the screw-thread stent, patient consent and tracheal diameter became the decisive factors in the choice of the stent. The use of the screw-thread stent was approved by the Medical Ethics Committee of our institution.
Stents
Dumon stents for tracheal stenosis (TD series) (Fig 1, right) 14 or 16 mm in diameter, with a variable length of 30 to 60 mm. Screw-thread stents (Fig 1, left) 17mm in diameter, with a variable length of 30 to 60 mm.
Stent Introduction Techniques
All procedures were performed in a fully equipped endoscopy suite or operating theater, under general IV anesthesia using propofol, alfentanil and atracurium. The patients were intubated with a rigid bronchoscope (Efer-Dumon; La Ciotat, France) bronchoscope. Appropriate ventilation and oxygenation were ensured by high-frequency jet ventilation with variable fractional inspiratory oxygen concentrations, delivered via a side port of the bronchoscope. After evaluation of the nature, dimension, and characteristics of the stenosis, Nd-YAG laser therapy was performed when indicated. Thereafter, a stenting procedure was performed. If a Dumon stent was chosen, a simplified insertion technique 7 was used: the appropriate stent was folded longitudinally, introduced in a siliconized bronchoscope shaft, and advanced into the stenosis by means of an alligator forceps. Using this procedure, no major problems have been encountered. The screw-thread stents, having a fixed outer diameter of 17 mm, were introduced as previously described 6 : the screw-thread stent and a plastic pusher tube were mounted over the tip of the bronchoscope, this configuration was passed through the glottis and introduced at the level of the stenosis, and the stent was deployed by holding the pusher tube firmly while retracting the bronchoscope. With this technique no vocal cord laceration, arytenoid luxation, or other glottic damage was observed. Furthermore, this technique allowed stent insertion to be done under direct vision, thus minimizing the need for adjustments after stent placement. 
Results
There were no major complications and no perior postoperative mortality. All stent insertions were well tolerated; in the majority of patients, minor early complications included temporary hoarseness and sore throat. Vocal cord edema with some degree of stridor occurred in four patients: once after Dumon stenting (3%), and three times after screwthread stenting (14%; not significant) ( Table 2 ). In both treatment groups, an equal proportion of patients (62% of the Dumon group and 67% of the screw-thread group) had uncomplicated and clinically successful stent treatment. Stent migration seemed to occur more often in the Dumon group than in the screw-thread group, respectively: 24% vs 5%. This difference did not reach statistical significance (p ϭ 0.1), however, probably because of ␤-error. All migrations occurred in benign tracheal stenoses (and all except one [goiter] in postintubation tracheal lesions); and no migrations occurred in the malignant tracheal stenosis group, respectively: 8 of 23 vs 0 of 23, p ϭ 0.004. Within the benign stenosis patient group, a significantly increased migration risk was associated with the Dumon stent when compared to the screw-thread stent, respectively: 7 out of 13 vs 1 out of 11, p ϭ 0.033. Late complications included suppurative bronchitis, which in every case could be treated successfully with antibiotics, and granuloma formation at the proximal or distal end of the stent, which was not treated, except in one patient who had an Nd-YAG laser photoresection. The occurrence of both of these late complications was similar in both treatment groups. Sputum adherence and desiccation on the inner stent surface were seen at regular fiberbronchoscopic follow-up in virtually all patients in both study groups, although every patient was instructed to use aerosol treatment with saline and/or a mucolytic agent at least once daily. Major problems such as stent obstructions or "retro-obstructive" complications attributed to this phenomenon were not seen. The most annoying problem in these patients was a foul-smelling breath.
Discussion
In this retrospective study, the silicone Dumon stent and the newly designed screw-thread stent were shown to have an equal clinical efficacy and complication rate in the treatment of benign and malignant tracheal stenosis. There was, however, a trend toward a decreased incidence of migration for the screw-thread stent in both patient groups, and a significantly lower migration rate for the screw-thread stent in patients with benign tracheal stenoses.
The migration of tracheal silicone stents occurs in about one in five patients. [3] [4] [5] Benign subglottic (most often postintubation or post-tracheostomy) stenoses are especially prone to stent migration because of the often short stenosis and the absence of extrinsic compression. This is confirmed by our findings of a 16% migration incidence in the whole patient population, the majority of which occurred in postintubation stenosis.
Stent migration can be prevented using a variety of methods, all with specific pros and cons. In patients with a tracheostoma, or in patients anticipating a tracheotomy, the placement of a Montgomery Ttube 8 (Novatech; Aubagne, France) probably represents the best therapeutic option. In other patients, the placement of an inverted y-shaped tracheal stent, saddled on the carina, may be preferred. 5 Disadvantages of this option are that the whole of the tracheal length including both main bronchi has to be "covered" for a very small subglottic stenosis, and the relatively elevated cost. In selected patients, external fixation of "classical" silicone Dumon stents by means of a transcutaneous suture 9,10 may also be considered. Theoretically, an increased risk of local infection, problems with deglutition, and more cumbersome emergency stent removal may complicate this technique. 9 Finally, newly developed stents designed for increased fixation especially in a short (eg, postintubation) stenosis may also be considered. Such stents are now available in the Dumon series. Based on our experience, a valid alternative is offered by the screw-thread stent, especially for use in benign tracheal stenosis: it is less expensive (approximately one third of the price of a Dumon stent, and one tenth of the price of a Dynamic Y stent; Novatech); it is equally efficient and less prone to migration than the Dumon stent; and it is as easy to introduce and remove as the Dumon stent. The need for prospective studies with larger patient groups is indicated to confirm these results.
